A point mutation in the linker domain of mouse STAT5A is associated with impaired NK-cell regulation
Salma Chehboun1,2, Gabriel André Leiva-Torres1,2, Benoît Charbonneau1,2
1Department of Human Genetics, McGill University, Montreal, QC, H3A 0C7, Canada.
Abstract:
The transcription factor STAT5 is critical for peripheral NK-cell survival, proliferation, and cytotoxic function. STAT5 refers to two highly related proteins, STAT5A and STAT5B. In this study, we verified the importance of STAT5A isoform for NK cells. We characterized an incidental chemically induced W484G mutation in the Stat5a gene and found that this mutation was associated with a reduction of STAT5A protein expression. Closer examination of NK-cell subsets from Stat5a mutant mice showed marked reductions in NK-cell number and maturation. IL-15 treatment of Stat5a mutant NK cells exhibited defective induction of both STAT5 and mTOR signaling pathways and reduced expression of granzyme B and IFN-γ. Finally, we observed that Stat5a mutant mice revealed more tumor growth upon injection of RMA-S tumor cell line. Overall, our results demonstrate that the W484G mutation in the linker domain of STAT5A is sufficient to compromise STAT5A function in NK-cell homeostasis, responsiveness, and tumoricidal function.
Insights
A STAT5A gene mutation impairs natural killer (NK) cell function, reducing their numbers, maturation, and ability to fight tumors. This STAT5A mutation compromises NK-cell homeostasis and tumoricidal activity.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Signal transducer and activator of transcription 5 (STAT5) is essential for natural killer (NK) cell functions.
- STAT5 exists as two isoforms: STAT5A and STAT5B.
Purpose of the Study:
- To investigate the specific role of the STAT5A isoform in NK cell biology.
- To characterize a novel W484G mutation in the Stat5a gene and its impact on NK cell function.
Main Methods:
- Analysis of NK-cell subsets from Stat5a mutant mice.
- Assessment of STAT5 and mTOR signaling pathways following IL-15 treatment.
- Evaluation of granzyme B and IFN-γ expression.
- Tumor growth assay using the RMA-S cell line in Stat5a mutant mice.
Main Results:
- The W484G mutation in Stat5a led to reduced STAT5A protein expression.
- Stat5a mutant mice displayed decreased NK cell numbers and impaired maturation.
- IL-15 stimulation resulted in defective STAT5 and mTOR signaling, and reduced granzyme B and IFN-γ in mutant NK cells.
- Stat5a mutant mice showed increased tumor growth.
Conclusions:
- The W484G mutation in STAT5A's linker domain significantly impairs NK cell homeostasis, responsiveness, and tumor-killing capabilities.
- STAT5A is crucial for maintaining NK cell function and anti-tumor immunity.
